{
    "clinical_study": {
        "@rank": "41947", 
        "acronym": "SCORE", 
        "arm_group": {
            "arm_group_label": "(suspected) NSCLC, mediastinal staging, endosonography", 
            "description": "Patients with potentially medically operable and resectable NSCLC are eligible if there is an indication for pathological evaluation of mediastinal lymph nodes."
        }, 
        "brief_summary": {
            "textblock": "Rationale: Lung cancer is the most commonly diagnosed cancer worldwide and is the most\n      frequent cause of cancer death. Accurate staging is important because it directs treatment\n      and prognosis. Mediastinal staging can be done by both EBUS-TBNA and EUS-FNA. These two\n      techniques have a complementary diagnostic range and the combined procedure is suited for\n      assessment of almost the entire mediastinum. In practice, when mediastinal tissue staging is\n      indicated, endoscopists often perform either an EBUS or an EUS investigation (instead of the\n      combined procedure).  Second, frequently only one or two, by imaging suspected lymph node\n      stations, are sampled (ie. targeted approach).\n\n      Objectives: main and secondary:\n\n        1. Complete endosonographic (combined endobronchial and esophageal) staging using a single\n           EBUS scope improves locoregional staging (N2, N3, T4) versus EBUS staging alone.\n\n        2. Systematic mediastinal staging results in improved locoregional staging compared to\n           PET-CT directed assessment of the mediastinum (ie targeted approach).\n\n      Study population: Patients with potentially operable and resectable NSCLC are eligible if\n      there is an indication for mediastinal nodal sampling. Patients have an indication for\n      EBUS-TBNA.\n\n      Intervention: Patients will undergo an EBUS investigation followed by EUS-B in the same\n      session. During this single scope procedure, lymph nodes that are suspected on prior CT-PET\n      imaging and on subsequent ultrasound are sampled.\n\n      Main study endpoint: The main study parameter is the sensitivity for locoregional disease\n      (N2, N3, T4 disease) of complete endosonographic staging (by EBUS-TBNA and EUS-B-FNA) in\n      comparison with EBUS staging alone."
        }, 
        "brief_title": "Single Scope Staging of Lung Cancer With Endosonography", 
        "condition": [
            "Non Small Cell Lung Cancer (NSCLC)", 
            "Indication Mediastinal Staging", 
            "Complete Endosonography"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Carcinoma, Non-Small-Cell Lung", 
                "Lung Neoplasms"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  (Suspected) NSCLC;\n\n          -  Indication for mediastinal nodal assessment;\n\n          -  Suspected mediastinal lymph nodes within reach of EBUS;\n\n          -  Age 18 years or older;\n\n          -  Clinically fit to undergo surgical resection of the lung tumor;\n\n          -  Provision of a written informed consent;\n\n        Exclusion Criteria:\n\n          -  Mediastinal re-staging after neo-adjuvant treatment;\n\n          -  Indication for EUS other than mediastinal staging, eg a for malignancy\n\n          -  suspected left adrenal;\n\n          -  Active malignancy with a life expectancy of less than two years;\n\n          -  Former therapy for lung cancer (chemotherapy, radiotherapy or surgery);\n\n          -  Technical contraindication for  EBUS or EUS (eg, esophagus stenosis);\n\n          -  Pregnancy;\n\n          -  Inability to consent;"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Patients with potentially operable and resectable NSCLC are eligible if there is an\n        indication for mediastinal nodal sampling. Patients have an indication for EBUS-TBNA."
            }
        }, 
        "enrollment": {
            "#text": "215", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 30, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02014324", 
            "org_study_id": "NL42787.018.13"
        }, 
        "intervention": {
            "arm_group_label": "(suspected) NSCLC, mediastinal staging, endosonography", 
            "description": "Complete endosonographic mediastinal staging is performed in 2 steps:\nSystematic EBUS (airways)\nSystematic EUS-B (esophagus)", 
            "intervention_name": "Endosonography", 
            "intervention_type": "Procedure", 
            "other_name": [
                "EBUS", 
                "EUS-B"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 12, 2013", 
        "location": [
            {
                "contact": {
                    "last_name": "K Tournoy, MD PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "Aalst", 
                        "country": "Belgium"
                    }, 
                    "name": "Onze-Lieve-Vrouwen-Ziekenhuis"
                }, 
                "investigator": {
                    "last_name": "K Tournoy, MD PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "C Dooms, MD PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "Leuven", 
                        "country": "Belgium"
                    }, 
                    "name": "Universitair Ziekenhuis Leuven"
                }, 
                "investigator": {
                    "last_name": "C Dooms, MD PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "P Clementsen, MD PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "Copenhagen", 
                        "country": "Denmark"
                    }, 
                    "name": "Copenhagen University Hospital"
                }, 
                "investigator": {
                    "last_name": "P Clementsen, MD PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "l.m.crombag@amc.nl", 
                    "last_name": "Laurence MMJ Crombag, MD", 
                    "phone": "+31205664356"
                }, 
                "contact_backup": {
                    "email": "j.t.annema@amc.nl", 
                    "last_name": "Jouke T Annema, Prof Dr", 
                    "phone": "+3120564356"
                }, 
                "facility": {
                    "address": {
                        "city": "Amsterdam", 
                        "country": "Netherlands", 
                        "state": "Noord-Holland", 
                        "zip": "1105AZ"
                    }, 
                    "name": "Academic Medical Center"
                }, 
                "investigator": {
                    "last_name": "Laurence MMJ Crombag, MD", 
                    "role": "Sub-Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "a.welling@mca.nl", 
                    "last_name": "A Welling, MD", 
                    "phone": "+31-72 - 548 27 50"
                }, 
                "facility": {
                    "address": {
                        "city": "Alkmaar", 
                        "country": "Netherlands"
                    }, 
                    "name": "Medisch Centrum Alkmaar"
                }, 
                "investigator": {
                    "last_name": "A Welling, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "JMA Daniels, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Amsterdam", 
                        "country": "Netherlands"
                    }, 
                    "name": "Vrije Universiteit Medisch Centrum"
                }, 
                "investigator": {
                    "last_name": "JMA Daniels, MD PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "w.buikhuisen@nki.nl", 
                    "last_name": "WA Buikhuisen, MD PhD", 
                    "phone": "+31-20 - 512 29 58"
                }, 
                "facility": {
                    "address": {
                        "city": "Amsterdam", 
                        "country": "Netherlands"
                    }, 
                    "name": "Antoni van Leeuwenhoek ziekenhuis"
                }, 
                "investigator": {
                    "last_name": "WA Buikhuisen, MD PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "S.R.S.Ramai@lumc.nl", 
                    "last_name": "SRS Ramai, MD", 
                    "phone": "+31-71 - 526 29 50"
                }, 
                "facility": {
                    "address": {
                        "city": "Leiden", 
                        "country": "Netherlands"
                    }, 
                    "name": "Leids Universitair Medisch Centrum"
                }, 
                "investigator": {
                    "last_name": "SRS Ramai, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "h.vanderheijden@longumcn.nl", 
                    "last_name": "HFM van der Heijden, MD", 
                    "phone": "024 - 361 45 79"
                }, 
                "facility": {
                    "address": {
                        "city": "Nijmegen", 
                        "country": "Netherlands"
                    }, 
                    "name": "Universitair Medisch Centrum st Radboud"
                }, 
                "investigator": {
                    "last_name": "HFM van der Heijden, MD PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "j.a.stigt@isala.nl", 
                    "last_name": "JA Stigt, MD", 
                    "phone": "+31-38 - 424 24 56"
                }, 
                "facility": {
                    "address": {
                        "city": "Zwolle", 
                        "country": "Netherlands"
                    }, 
                    "name": "Isala klinieken"
                }, 
                "investigator": {
                    "last_name": "JA Stigt, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "Belgium", 
                "Denmark", 
                "Netherlands"
            ]
        }, 
        "number_of_groups": "1", 
        "official_title": "Complete Endosonographic Staging of Lung Cancer: a Systematic Single Scope Approach", 
        "overall_official": {
            "affiliation": "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)", 
            "last_name": "Jouke T Annema, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Sensitivity is defined as number of true positives (pathologic proof of a nodal metastases) divided by the number of true positives and false negatives (thoracotomy with nodal dissection is the reference standard to detect false negatives).\nThe main study parameter is the sensitivity for locoregional disease (N2, N3, T4 disease) of complete endosonographic staging (by EBUS-TBNA and EUS-B-FNA) in comparison with EBUS staging alone.\nIn the event of pathological proof of mediastinal metastases (N2/N3) by endosonography patients are classified as having locally advanced disease (stage III) and the study stops. When no mediastinal metastases are found by endosonography, surgical verification will take place (reference standard).", 
            "measure": "Sensitivity for locoregional disease (N2, N3, T4 disease).", 
            "safety_issue": "No", 
            "time_frame": "from inclusion untill either pathological proof of mediastinal metastases by endospnography or 1 week after surgical verification"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02014324"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)", 
            "investigator_full_name": "Prof J.T. Annema", 
            "investigator_title": "MD PhD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Sensitivity for locally advanced disease (N2-3 metastases, T4) of systematic assessment and sampling of mediastinal lymph nodes in comparison to PET-CT directed assessment of the mediastinum (ie targeted approach).", 
            "measure": "Sensitivity for locally advanced disease (N2-3 metastases, T4). Systematic assessment and sampling of mediastinal lymph nodes versus PET-CT directed assessment of the mediastinum.", 
            "safety_issue": "No", 
            "time_frame": "from inclusion untill either pathological proof of mediastinal metastases by endosonography or 1 week after surgical verification"
        }, 
        "source": "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "4 Weeks", 
        "verification_date": "December 2013"
    }
}